Once lauded as an unstoppable growth machine, Valeant Pharmaceuticals has been mired in controversy and has seen its stock plunge over 70% over the last three months. Needless to say, Valeant is struggling to gain traction from its precipitous slide. To provide some brief context, Valeant’s mass sell-off was triggered by a report released […]
Apple this, Apple that. What started as a small personal computer company has now transformed into a tech industry juggernaut. Irrespective of what your opinion may be regarding Apple’s products, there is no doubting Apple’s remarkable ability to grow. Hailey Cole’s (section 105) blog discusses Apple’s foray into the online music streaming space. She explains […]
On scale alone, the colossal merger of beer giants Anhesuer-Busch (AB) and SABmiller warrants some appreciation. The $100 billion dollar transaction creates an unprecedented powerhouse in the global brewing market, one in which trumps its nearest competitor from a market share perspective by three fold. Large-scale M&A deals have always fascinated me. The financials alone […]